Glucose Health, Inc (GLUC) financial statements (2020 and earlier)

Company profile

Business Address 609 SW 8TH STREET
BENTONVILLE, AR 72712
State of Incorp. NV
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2121012
Cash and cash equivalents2121012
Receivables123   
Inventory, net of allowances, customer advances and progress billings 8 25
Inventory 8 25 
Prepaid expense1139 
Other undisclosed current assets 0(5)(1)(1)
Total current assets:331544261
Noncurrent Assets
Intangible assets, net (including goodwill)000207
Intangible assets, net (excluding goodwill)000 207
Total noncurrent assets:000 207
TOTAL ASSETS:33154426208
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:13895155145123
Accrued liabilities50   
Other undisclosed accounts payable and accrued liabilities13395155145123
Debt39617086121
Deferred compensation liability   (17)(150)
Due to related parties112  22
Other undisclosed current liabilities240302 889
Total current liabilities:529403325223185
Noncurrent Liabilities
Total liabilities:529403325223185
Stockholders' equity
Stockholders' equity attributable to parent, including:(495)(388)(281)(198)22
Preferred stock113113113  
Common stock32119101
Common stock, value, subscriptions2323 
Additional paid in capital1205,3865,2284,7433,589
Accumulated other comprehensive loss(75)(75)(75)(75)(75)
Accumulated deficit(6,248)(5,837)(5,571)(2,874)(2,874)
Other undisclosed stockholders' equity attributable to parent5,568 23(2,011)(719)
Total stockholders' equity:(495)(388)(281)(198)22
TOTAL LIABILITIES AND EQUITY:33154426208

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues31343  
Revenue, net31343(0) 
Cost of revenue(294)(4)(3)(2)(16)
Cost of goods and services sold (4)(23)(200)(16)
Other undisclosed gross profit  (21)0 
Gross profit:190(21)(2)(16)
Operating expenses(106)(157)(524)(1,267)(361)
Other undisclosed operating income    16
Operating loss:(87)(156)(545)(1,269)(361)
Nonoperating expense(324)(110)(124)(190)(38)
Debt instrument, convertible, beneficial conversion feature (110) (173)(34)
Interest and debt expense(324)(120)(110)(169)(38)
Loss from continuing operations before equity method investments, income taxes:(734)(386)(779)(1,628)(437)
Other undisclosed income from continuing operations before income taxes324120110169 
Loss before gain (loss) on sale of properties:(410)(266)(669)(1,459)(437)
Other undisclosed net income    32
Net loss:(410)(266)(669)(1,459)(405)
Other undisclosed net income attributable to parent    6
Net loss available to common stockholders, diluted:(410)(266)(669)(1,459)(399)

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(410)(266)(669)(1,459)(405)
Comprehensive loss, net of tax, attributable to parent:(410)(266)(669)(1,459)(405)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: